©2022 Stanford Medicine
Clinical Trials Contact
About this Clinical Trial
Efficacy and Safety Study of Tisotumab Vedotin for Patients With Solid Tumors
Your Message Will Go To
Sabrina Biedermann
(650) 498-6000
Efficacy and Safety Study of Tisotumab Vedotin for Patients With Solid Tumors
Sabrina Biedermann
(650) 498-6000